Nykode Therapeutics
Develops immunotherapies for patients with cancer and autoimmune diseases using a modular biotech platform
Highlights
- New on EvolcAdded 2026-10-27
About Nykode Therapeutics
Nykode Therapeutics is a clinical-stage biopharmaceutical company developing immunotherapies based on its Vaccibody molecule and modular platform. Its research targets cancer and autoimmune diseases.
The company was founded in 2006 and is headquartered in Oslo, Norway. It also presents an office in Lyngby, Denmark.
Product: A modular immunotherapy platform and candidate medicines for cancer and autoimmune diseases.
Jobs at Nykode Therapeutics
No open positions listed right now.
More biotech & pharma companies
Oncosyne
Tumoroid-based drug screening and predictive diagnostics for pharmaceutical companies and cancer care providersNew on EvolcPharma Holdings
Develops intranasal antimicrobial drugs for patients with respiratory viral infectionsNew on EvolcPluvia
Develops small-molecule drugs for patients with rare protein-misfolding disorders, starting with phenylketonuria (PKU)New on EvolcPreviwo
Probiotic products for farmed salmon and trout that strengthen fish health in aquacultureNew on EvolcProphylaxia
Researches salmon signalling substances such as SNAP as a sea lice alternative for salmon farmingNew on EvolcQuantidoc
Immune barrier health monitoring for fish farms and hatcheries using its VERIBARR™ analyses of gills, skin and gutNew on Evolc
Website technologies
Older, unverified list. Detection dates and supporting evidence are not yet available.
- Apache
- BambooHR
- Cloudflare
- CookieYes
- Google Tag Manager
- PHP
- WordPress
- jQuery